# Rizatriptan

## Rizatan 5mg

##### 

| TAH Drug Code      | ORIZ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute treatment of migraine with or without aura                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | Migraine, acute: Adult: 5-10 mg, repeat after 2 hours if significant relief is not attained; maximum: 30 mg/24 hours. Children 6-17 years old: < 40 kg, 5 mg; > 40 kg, 10 mg. Maximum: 1 dose/24 hour. Children with concomitant propranolol use: > 40 kg, 5 mg in a 24-hour period; < 40 kg, rizatriptan is not recommended.                                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity to rizatriptan or any component of the formulation; documented ischemic heart disease or other significant cardiovascular disease; coronary artery vasospasm (including Prinzmetal's angina); history of stroke or transient ischemic attack; peripheral vascular disease; ischemic bowel disease; uncontrolled hypertension; basilar or hemiplegic migraine; during or within 2 weeks of MAO inhibitors; during or within 24 hours of treatment with another 5-HT1 agonist, or an ergot-containing or ergot-type medication (eg, methysergide, dihydroergotamine)                                                                                                                                         |
| Adverse Effects    | Cardiovascular: Chest pain (<3%), flushing (>1%), palpitations (>1%), flushing Central nervous system: Dizziness (4% to 9%), drowsiness (4% to 8%), fatigue (adults: 4% to 7%; children: >1%), paresthesia (3% to 4%), pain (3%), feeling of heaviness (<2%), headache (<2%), euphoria (>1%), hypoesthesia (>1%) Gastrointestinal: Nausea (4% to 6%), xerostomia (3%), sore throat (<2%), abdominal distress (children: >1%), diarrhea (>1%), vomiting (>1%) Neuromuscular & skeletal: Weakness (4% to 7%), jaw pain (<2%), jaw pressure (<2%), jaw tightness (<2%), neck pain (<2%), neck pressure (<2%), neck tightness (<2%), tremor (>1%) Respiratory: Pharyngeal edema (<2%), pressure on pharynx (<2%), dyspnea (>1%) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

